Antiphospholipid Syndrome Is Still a Rare Disease—Estimated Prevalence in the Piedmont and Aosta Valley Regions of Northwest Italy: Comment on the Article by Duarte‐García et al
Massimo Radin(Ospedale San Giovanni Bosco), Simone Baldovino(Azienda Ospedaliero Universitaria San Giovanni Battista), Tiziana Bertero, Irene Cecchi(Ospedale San Giovanni Bosco), Savino Sciascia(Ospedale San Giovanni Bosco), A Vaccarino(Istituto di Ematologia di Bologna), R. Carignola(Ospedale San Luigi Gonzaga), Elena Rubini(Ospedale San Giovanni Bosco), Barbara Montaruli(A. O. Ordine Mauriziano di Torino), Erika Montabone(Ospedale San Luigi Gonzaga), Mario Bazzan(Ospedale San Giovanni Bosco), Dario Roccatello(5T Torino (Italy))
Cited by 25
Related Papers
Three Months versus One Year of Oral Anticoagulant Therapy for Idiopathic Deep Venous Thrombosis
|New England Journal of Medicine|2001|599
GAPSS: the Global Anti-Phospholipid Syndrome Score
|Lara D. Veeken|2013|310
Enoxaparin for the Prevention of Venous Thromboembolism Associated With Central Vein Catheter: A Double-Blind, Placebo-Controlled, Randomized Study in Cancer Patients
|Journal of Clinical Oncology|2005|305
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study
|Arthritis & Rheumatology|2021|165
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients
|Internal and Emergency Medicine|2008|126